Genome Medical is the largest tele-genetic counseling provider in the U.S, offering a network of genetic clinicians and expertise across six specialties: cardiovascular, oncology, health screening, reproductive health, pediatrics and pharmacogenomics. Genome Medical’s Genome Care Delivery™ platform and clinician network position it as the only provider capable of delivering low-cost, high quality genetic counseling to large healthcare systems.
CEO: Jill Davies (formerly Lisa Alderson)
Headquarters: South San Francisco, CA
Year Founded: 2016
Year Avestria First Invested: 2020 (Fund I)
Looking for a job opportunity at Genome Medical? Click here.
Recent Press:
Genome Medical uses specially formatted clinical-grade data to boost genomics
FDNA and Genome Medical partner
Genome Medical is a 2024 MedTech Breakthrough winner
Genome Medical wins Brandon Hall Group HCM Excellence Silver Award
Genome Medical recognized as one of America’s fastest growing companies on the 2023 Inc. 5000 list
Genome Medical supporting Beam Therapeutics on sickle cell disease clinical trial
Genome Medical wins Genomics Innovation Award
Genome Medical is at the Molecular & Precision Med TRI-CON 2023
Genome Medical and xCures announce partnership
The Life Science Tools Market Report 2022
Genome Medical is at the 2022 American Society of Human Genetics annual meeting
Lisa Alderson is a speaker at the Illumina Genomics Forum
Genome Medical selected as quarterfinalist for the UCSF Health Awards
Lisa Alderson is a conversation leader at the Health Innovation Summit
Genome Medical and Pierian announce collaboration to optimize genetic testing programs
Colleen Caleshu, MS, LCGC presents on practical applications of genetic information
Genome Medical partners with the Hereditary Neuropathy Foundation for CMT Genie Project
Genome Medical is presenting at the Precision Medicine World Conference 2022
Gender affirming care in genetic counseling
The business case for investing in genomics
Lisa Alderson joins Adela Inc.’s Board of Directors
Myriad Genetics, a Genome Medical partner, reports first quarter results
Raise the Bar Smart Money podcast: Lisa Alderson - Force For Good
Genome Medical named one of America’s best startup employers
The Pharmacy Podcast interviews Dr. Gillian Bell, Pharmacogenomics Lead at Genome Medical
Genome Medical’s Scott Weissman on team behind NSGC’s Lynch Syndrome Practice Resource
Genome Medical partners with GRAIL to provide access to a multi-cancer early detection blood test
Genome Medical joins coalition supporting Seven Bridge Genomics’ Unified Patient Network
Genome Medical is one of the CB Insights’ top digital health companies of 2021
Genetic Testing for Stomach Cancer Webinar: The Who, What, Where and Why You Should Be Tested
A day in the life of Maria-Renee Coldagelli, one of Genome Medical's genetic counselors
Genome Medical partners with Invitae and Outcomes4Me
Genomic Medicine: how to go from cutting edge to commonplace for all
Humanity Changemaker of the Week: Lisa Alderson
Physician-directed genetic screening to evaluate personal risk for medically actionable disorders
Genome Medical announces acquisition of GeneMatters and closing of $60M Series C financing
Genome Medical’s Molly McGinniss MS, CGC elected as ACGC President
Tracxn’s Top Diagnostic Tech Startups
Four ways genomics will advance clinical care (by Lisa Alderson)
PTC Therapeutics, Genome Medical, and Invitae partnering for PTC Pinpoint Direct™ Program
Genome Medical expands Board of Directors and Leadership Team
The Next Wave with Young Sohn: Genomics & the Future of Healthcare with Lisa Alderson
5 Key Trends in Digital Health for 2021 - and 10 Companies to Watch
Genome Medical wins “Best Digital Health Company to Work For” award
Healthcare Trends That Will Rule 2021
Slice of Healthcare: Lisa Alderson
Webinar: Reimaging Population Health Management
‘
Genome Medical reaches 90 million covered lives
Genomics is evolving from niche to center stage
Health Podcast Network: Lisa Alderson
Global genomic medicine market competitive landscape outlook
Top Women in Precision Medicine: Lisa Alderson
This entrepreneur raised $60M to bring genetics to everyday life
Understanding your personal and genetic health
Genome Medical on CB Insights’ 2020 list of digital health front-runners
Genome Medical aims to plug a genetics gap
Genome Medical announces $14M round
Genome Medical is leading the way
Genome Medical celebrates fourth anniversary
Should everyone have their full genome sequenced?
Of Known Significance: genomics-driven healthcare
Lisa Alderson on her telegenetics firm and the DTC downturn
5th International Day of Women and Girls in Science Assembly
Lisa Alderson is the inaugural recipient of the Tom Main Health Innovation Mentorship
May 23, 2024: Last year, Genome Medical announced its partnership with xCures; this article goes into detail about that partnership’s benefits to patients, clinical trial organizers, and others. For example, xCures allows Genome Medical to augment the medical records it has for patients - safely, securely, and with patient consent. This additional information helps Genome Medical identify patients who meet clinical trial criteria: a potential benefit for not only the current patient but also future patients. In one instance, a clinical trial needed participants for an ultra-rare disease that affects one in 70,000-100,000 people. Genome Medical, through the data it and xCures have collectively, identified seven eligible patients.
May 20, 2024: Genome Medical has partnered with FDNA Inc, which detects rare genetic diseases early. Now, the FDNA app identifies patients with potential genetic connections and connects them with Genome Medical for genetic assessments, counseling, and services. This partnership not only can decrease the time needed to reach an accurate diagnosis but also can provide diagnostic and genetic health services to those who may face barriers when trying to access this type of care in-person. After all, around 6,000 families access FDNA's app monthly and on average, 90% live more than an hour drive from a medical center and 80% are from small towns and rural areas that are often medically underserved.
May 9, 2024: Now in their eighth year, the MedTech Breakthrough awards honor the companies, technologies, and products shaping not only digital health but medical technology in general. Submissions are open to the public and reviewed by an independent organization. Genome Medical won the “Best Overall Genetics Company” this year and, in the process, joins previous MedTech Breakthrough award winners including established players such as Amazon, GoodRx, Hologic, and MedTronic as well as deserving startups.
August 25, 2023: Genome Medical has won a silver medal in the Brandon Hall Group Excellence Awards in the Human Capital Management (HCM) category. Specifically, Genome Medical’s RISE Patient Engagement Modules, which were created by Genome Medical’s Education and Engagement Team as well as Ninja Tropic, an animation company, to increase access to genetic services and support patient decision-making: from scheduling to genetic risk assessments to education. The Brandon Hall Group Excellence Award recipients are chosen by industry experts, executives, and Brandon Hall analysts are are judged based on business need and alignment, program design, functionality, and delivery, and overall effectiveness, impact, and measurable benefit.
August 24, 2023: For Healthcare Innovation’s Telehealth and Virtual Care Virtual Day, Genome Medical’s CEO Jill Davies sat down with Mark Hagland, editor-in-chief of the Healthcare Innovation magazine. In the subsequent printed interview, she answers six questions. What role do telehealth genetic services play in health systems? How can health systems use telehealth to improve access to genomic care? How can telehealth address workface shortage issues? What learnings in genetics specifically can be applied to telehealth broadly? How are genetic technology solutions providing downstream service opportunities for health systems? How will the overall genetics services landscape evolve in the future?
August 16, 2023: The annual Inc. 5000 list recognizes the most successful, independent, entrepreneurial businesses. Genome Medical joins this year’s list of America’s fastest-growing companies, ranking 663 total for its fast growth despite inflation and rising costs. Past honorees on the Inc. 5000 list include companies such as Facebook, Chobani, Under Armour, Microsoft, and Patagonia.
June 22, 2023: Gundersen Health System, an integrated healthcare network, Edge, Gundersen’s innovative arm, and Genome Medical are partnering to expand Gundersen’s genetic and preventative care services. Genome Medical will work with Gundersen’s genetic counselors to help provide pre- and post-test counseling to patients with hereditary cancer risks. This collaboration can help expand Gundersen's geographic reach and service delivery, reduce counseling appointment wait times from about 10 months to under seven days, and maintain a high quality of care.
May 25, 2023: Sickle cell disease is a genetic disorder that can distort red blood cells, blocking the flow of blood and oxygen throughout the body, causing anemia, chronic pain, infections, organ damage, and death. Beam Therapeutics is conducting a clinical trial to evaluate its product, BEAM-101, as a potential treatment for this disease. As part of the clinical trial, Beam Therapeutics will sponsor genetic counseling, resources, and support through Genome Medical for the trial participants.
May 3, 2023: Genome Medical’s RISE Risk Assessment Module won the “Genomics Innovation Award” as part of the annual MedTech Breakthrough Awards program. MedTech Breakthrough is a third-party market intelligence organization focused on the global health and medical technologies market. The 2023 Awards, which mark the seventh consecutive year these awards have been given, recognized companies across clinical and health administration, care management and delivery, genomics, and more.Another Avestria portfolio company, Avation Medical, won the MedTech Breakthrough Award for healthcare wearables innovation.
March 29, 2023: Genome Medical’s Molly McGinniss, Senior Director, Client and Partner Relations, Population Genomics, and Michelle Hearn, Clinical Science Liaison, teamed up for this webinar. Called “Accelerating clinical trials and sponsored testing programs using telgenetics,” the webinar covers the value of telegenetics to biopharmaceutical organizations, including how genetic counseling and services can help these biopharma organizations efficiently find the right patients that qualify for clinical trial.
March 6, 2023: Two Genome Medical associates are speaking at the Molecular & Precision Med TRI-CON 2023 conference, which helps bring together the diagnostics and precision medicine community. Colleen Caleshu ScM, CGC, Genome Medical’s Senior Director, Clinical Research will be presenting "A Patient-Administered Digital Tool Is Efficient, Usable, and Effective at Identifying Patients with Hereditary Cancer Risk, Enabling Prevention and Early Detection of Cancer". She’ll also join a panel called “Value Proposition and Market Access for Genomic Medicine”, which is moderated by felow Genome Medical associate Molly McGinniss, Genome Medical’s Senior Director, Population Genomics and Precision Medicine.
February 15, 2023: Genome Medical and xCures have partnered to increase the personalized clinical care. Through this collaboration, Genome Medical’s genetic counselors will have access to patients’ care summaries from xCures, which are based on patients’ collective medical records. This view helps Genome Medical counselors keep increasing the level of personalized care that they provide and potentially improve population health overall through this additional insights into both patients and inherited diseases, such as oncology.
December 29, 2022: The 2022 Life Science Tools Market Report was released and includes Genome Medical as one of its profiled companies. This report also highlights Genome Medical’s expansion of its technology infrastructure as an example of the “organic strategics” that “key market players”, such as Genome Medical, are pursuing that may, in turn, drive the global life science tools market.
October 26, 2022: Genome Medical is at Booth #1809 at the American Society of Human Genetics (ASHG) annual meeting. The company has also partnered with DeciBio and Pierian for a networking happy hour during the conference to bring together leaders and experts in the field of precision medicine. Details on the happy hour can be found here.
September 29, 2022: At the Illumina Genomics Forum, Lisa Alderson is leading a discussion on how to incorporate genomics in diverse clinical settings. The panel, called “Genomic Models of Practice That Support the Quadruple Aim” is one of the many at the Illumina Genomics Forum, which, this year, features a main stage spotlight with former president Barack Obama.
September 28, 2022: Genome Medical has been selected as a quarterfinalist in the “New Telehealth Innovation” category in the UCSF Health Hub Digital Health Awards. The ten quarterfinalists for each category are judged based on their product differentiation, value and credibility, and market traction. This year marks the second consecutive year that Genome Medical has been a quarterfinalist; in 2021, the company was recognized in the “New Application in Telehealth” category.
September 21, 2022: Lisa Alderson is one of the conversation leaders at the 2022 Health Innovation Summit, which focuses on new norms after the past two years - and the new innovations that must accompany them. Lisa’s talk “Making Genomics Available to All” was one of the center-stage presentations on Wednesday, September 21. She also joined other center stage speakers for a roundtable conversation over lunch later that day.
September 20, 2022: Genome Medical and Pierian, the leader in advanced clinical genomics technology and services, announced a collaboration aimed at optimizing genetic testing programs. Together, the two hope that they can efficiently identify patients who might benefit from genomic testing, conduct that testing and/or order the right tests through Genome Medical, process those tests in laboratories supported by Pierian, utilize Pierian’s tech to analyze, interpret, and report on the genomic insights, and, if needed, offer follow-up genetic counseling from a Genome Medical clinician. For organizations looking to offer these services, Pierian and Genome Medical offer a streamlined path to high-quality, precise, and personalized genetic testing.
August 18, 2022: Colleen Caleshu MS, LCGC, Genome Medical’s Senior Director of Clinical Research is speaking on the practical applications of genetic information. Her presentation is part of the Genetics Special Edition Bighearted Warriors Unite webinar hosted by the Hypertrophic Cardiomyopathy Association. Other topics covered in webinar will include what genes are involved in hypertrophic cardiomyopathy, where research is heading, and how to apply genetic knowledge - such as the testing results - to subsequent therapies.
August 9, 2022: Genome Medical has partnered with the Hereditary Neuropathy Foundation for the CMT Genie Project: a suite of services meant to help test for Charcot-Marie-Tooth (CMT) disease and to break down those results for patients. The project is meant to provide faster and more equitable access to CMT testing than there has been prior and to clear up the confusion about how and why to get tested. CMT, also known as hereditary motor and sensory neuropathy, is a group of hereditary genetic disorders that affects the nerves in the hands and legs. Through the CMT Genie Project, Genome Medical will provide an initial telehealth consultation, guidance for patients ordering genetic tests, and follow-up virtual appointments to help participants understand their results and get recommendations for any further needed care.
July 19, 2022: This analysis of the human genetics market covers the market size of, key players in, and overall analysis of the human genetics market. It also highlights companies like 23andMe and Genome Medical in its section about latest trends, citing these two companies as ones that have experienced high growth and are utilizing telehealth/digital platforms in order to reach potential customers.
June 30, 2022: Two Genome Medical associates are presenting at the Precision Medicine World Conference from June 28 to June 30, 2022. Steven Bleyl M.D, Ph.D, Genome Medical’s Chief Medical Officer, will be presenting on the “Scalable Approaches to Relaying Genomic Information to Clinicians and their Patients” panel on the second day of the conference (June 29) while Gillian Bell PharmD, Genome Medical’s Pharmacogenomics Service Lead, is part of the “PGx Innovative Solutions” panel. Her focus is on a novel approach to a nationwide pharmacogenomics medical practice.
June 16, 2022: Joanna Mercado, a genetic counselor specializing in hereditary cancer syndromes at Genome Medical, joins this panel on gender-affirming care along with Marney Brillinger of Brigham and Women’s Hospital and Holden Bender-Bernstein, a transgender singer, actor, educator, and social worker. Together, the three cover ways to improve the clinical experience for transgender and gender non-conforming patients, including addressing challenges, helping with education and advocacy in the genetics community, and collecting family history in a way that affirms the gender not only of the patient but of the patient’s family as well.
June 9, 2022: Lisa Alderson is joining a virtual discussion, hosted by The Academy, on the business case for investing in genomics; it will focus on the best ways to scale genomic care and precision medicine practices to attract consumers, generate revenue, and support necessary investments. This panel also features Feyi Olopade Ayodele, CEO & Co-Founder at CancerIQ, Dr. James Lu, CEO & Co-founder, Helix, and Dr. Phil Febbo, CMO, Illumina
May 23, 2022: Lisa Alderson has joined the Board of Directors at Adela Inc., which focuses on detecting cancer and other high-morbidity and high-mortality conditions through a blood test. Lisa brings her 20 years of experience in building early-stage companies, in commercialization, and in understanding healthcare to Adela and will serve as an Independent Director.
May 20, 2022: At the 16th annual Personalized Medicine Conference, Lisa Alderson joined fellow panelist Burns C. Blaxall, Ph.D. of the The Christ Hospital Health Network, Lincoln Nadauld, M.D., Ph.D. of Intermountain Healthcare, and Apostolia M. Tsimberidou, M.D., Ph.D. of The University of Texas MD Anderson Cancer Center. Their discussion - “Providing Personalized Medicine: Reflections from Representatives of Differently Structured Healthcare Systems” - allowed them to speak about their own experiences providing personalized care as members of a clinical integration partner institution, an academic medical center, an integrated health care delivery system, or a community healthcare system.
May 13, 2022: Erica Ramos, VP of Population Genomics at Genome Medical, and Heather Hampel, a member of Genome Medical’s Scientific Advisory Board, co-authored this article, which requests a “Call to Action” in order to ensure equity in DNA-based population screening. Their recommendations include identifying and eliminating systemic barriers that result in health inequities in DNA-based population screenings, creating a national multidisciplinary advisory committee with members from underserved communities, guiding new screening decisions and initiatives by taking another look at public health screening guidelines, and having local, state, and national entities adopt the updated Ten Essential Public Health Services, which focuses on equity.
May 6, 2022: Betsy Swope, MS, CGC, Director of Reproductive Genetic Services at Genome Medical, presented at the Illinois Society of Genetic Professionals (ISGP) Annual Genomics Symposium. Her presentation, which fell under the “telehealth” portion of the virtual event was titled, “A nationwide approach to reproductive telegenetic counseling” and, it, she covered successes, future opportunities and potential barriers in the field.
May 5, 2022: Myriad Genetics partnered with Genome Medical in February 2022 to offer to patients a virtual care solution that lead them through the end-to-end hereditary cancer testing process, including ordering a test to reviewing the results with a Genome Medical expert. This service, one of the several that Myriad Genetics added to its offerings, helped Myriad Genetics increase its revenue 11% year-over-year.
May 4, 2022: Erica Ramos, VP of Population Genomics at Genome Medical, and Molly McGinniss, Senior Director of Population Genomics at Genome Medical, are two of the co-authors for this article, which was published in the Journal of Genetic Counseling. The authors of this article assessed the barriers that ethnic minority genetic counselors in the United States and found regarding their professional career advancement and found value in mentorship and sponsorship programs in their workplace and in allyship from White colleagues.
March 24, 2022: Natalie Beck MGC, Lead Genetic Counselor, Pediatric and Rare Disease Services at Genome Medical, moderated a panel at the 2022 ACMG Annual Clinical Genetics Meeting. The panel focused on the challenges and opportunities of utilizing telemedicine and other alternate ways to deliver care and services to the pediatric genetic population. The speakers also shared their personal experiences with these alternate service delivery models before and during the COVID-19 pandemic.
March 14, 2022: For this episode of the Raise the Bar Smart Money podcast, host Juan Pablo Delgado interviews Lisa Alderson. Despite advancements in, necessity of, and benefits of genetic testing, it still remains inaccessible for many people. Lisa Alderson explains how exactly genetic medicine can change the game for individuals, including those looking to start families or those at risk of a life-threatening illness, why she wants to democratize access to genomic medicine, and what her five initiatives of change are.
March 8, 2022: Genome Medical was named one of Forbes’ best startup employers. Forbes, alongside market research company Statista, evaluated 2,500 U.S. businesses founded between 2021 and 2019 with at least 50 employees across three criteria: employer reputation, employee satisfaction and growth. The final list, the fourth annual one that Forbes has published, ranks 500 employers across all industries, including Advertising & Marketing, Education & EdTech, Healthcare, Media & Entertainment, and Retail.
January 10, 2022: The Pharmacy Podcast interviewed Gillian Bell, who is a Doctor of Clinical Pharmacy and Genome Medical’s Pharmacogenomics Lead. This 30-minute interview covers her background (including pharmacy school and her residency), her work at Genome Medical and why she joined the company, and her advice to pharmacists who want to pursue pharmacogenetics (PgX).
December 18, 2021: In a joint effort with the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC), the National Society of Genetic Counselors (NSGC) published a practice resource on lynch syndrome. Its goal is to help genetic counselors provide high-quality risk assessment, counseling, and testing for high-risk patients. The resource’s authors include Scott Weissman MS, CGC who is Genome Medical’s Director of Cancer Genetic Services.
December 15, 2021: Genome Medical is adding GRAIL’s new blood test, Galleri®, to its options of genomic tests. Galleri® detects 50 types of cancers, most of which are not commonly screened for; 68% of cancers deaths in adults aged 50 to 79 are caused by cancers for which individuals are not commonly screened. The oncology experts at Genome Medical have put together a list of patients who are at risk to develop cancer and, thus, who could benefit from Galleri®.
December 9, 2021: Genome Medical is one of the companies supporting the Unified Patient Network (UPN): a new subsidiary of Seven Bridges Genomics. UPN, a collaborative group of health systems, aims to build a database of participants’ de-identified clinical and genomic data to help research the genetic roots of health and diseases. Genome Medical, Amazon Web Services, the Broad Institute of MIT and Harvard, Illumina and other partners are helping to support this project and the collaboration and data required to sustain it.
December 8, 2021: Genome Medical was named one of CB Insights’ top 150 digital health companies of 2021. The company was chosen out of 11,000+ submissions based on factors including its business model and market momentum and CB Insights’ own analysis of each company’s health and growth. 2021 marks the third year in a row that Genome Medical has been on CB Insights’ top digital health companies list.
November 17, 2021: Sheryl Walker, MS, CGC - one of Genome Medical’s genetic counselors - and Jon Florin, Executive Director at No Stomach For Cancer, presented this webinar. Stomach cancer is one of the top three deadliest cancers in the world, and the two discussed who needs to be tested for stomach cancer, what tests they should have, where they should receive tests, and why they need those tests in the first place. The goal of this webinar is to raise awareness not only of stomach cancer but also the need for research funding, collaboration, and advocacy in addressing it.
November 2, 2021: For Genetic Counselor Awareness Day, which is normally hosted on the second Thursday of November, Maria-Renee Coldagelli, one of Genome Medical’s genetic counselors, shares a 90-second video about a typical day in her life, which includes looking at results from genetic tests, conducting phone visits and video calls, attending team meetings, and figuring out the right tests to give to a range of patients.
October 11, 2021: Genome Medical is partnering with Invitae and Outcomes4Me to help deliver its services to patients undergoing genetic testing for breast cancer. Outcomes4Me’s app and platform help patients navigate cancer treatment and care while Invitae, a medical genetic company, already had a partnership with Genome Medical. Together, the three can help expand education and access to genetic testing: breast cancer patients and survivors can receive genetic testing through Genome Medical and upload their results to the Outcomes4Me app.
September 27, 2021: Three of Genome Medical’s leaders are featured discussion leaders for this webinar about genomic medicine. Lisa Alderson (CEO), Randy Scott PhD (Co-Founder and Chairman), and Steven Bleyl MD, PhD (Chief Medical Officer) will talk about what changes genomic medicine has undergone, how feasible preventative genome screening programs are, and how genomic medicine can continue to improve patient outcomes.
September 13, 2021: Out of hundreds of companies, Genome Medical was chosen as a quarterfinalist for the “New Application in Telehealth” category in the annual UCSF Health Awards. These awards aim to recognize the technologies and innovations transforming healthcare across 14 categories, including AI, consumer wellness, diagnostics, life sciences, and telehealth,
September 10, 2021: Humanity Health named Lisa Alderson as its #HumanityChangemaker of the week. The #HumanityChangemakers series aims to amplify BIPOC and/or female innovators in healthcare, such as Lisa Alderson. This shoutout highlights her work not only as the CEO of Genome Medical but also as the former Chief Commercial Officer and Chief Strategy Officer of Invitae, as part of Genomic Health’s start-up team, and as a board member of the Kidney Cancer Association.
September 9, 2021: This webinar features three leaders at Genome Medical: Lisa Alderson (CEO), Steve Bleyl MD, PhD (Chief Medical Officer), and Erica Ramos MS, CGC (VP, Population Genomics) to discuss genomic care. Their conversation includes best practices for developing a genetic screening program, ways to reach health systems and patients, and the effect that the growth on genetic services and genomic medicine can have on the population at large.
August 18, 2021: This paper follows a multi-center cohort study on the yield and potential value of using genetic screening to detect monogenic disorders in healthy individuals. Monogenic disorders - or disorders that are caused by a mutation in a single gene - include sickle cell anemia, cystic fibrosis, and Huntington disease. Genome Medical’s co-founder, Robert Green MD, MPH, Chief Medical Officer, Steve Bleyl, MD, and Director of Cancer Genetic Services, Scott M Weissman MS, CGC, all helped contribute to this study and the subsequent report.
August 30, 2021: Genome Medical announced its acquisition of GeneMatters - another telehealth genetic counseling service: a partnership that allows both companies to reach an expanded network of providers and payors. Alongside the acquisition news, Genome Medical shared that it has closed its $60M Series C financing round. Alongside Avestria, the round included investors such as Amgen Ventures, Casden Capital, and GV (previously Google Ventures). These milestones can help Genome Medical continue to lead in the field of tele-genetic health services.
August 4, 2021: Molly McGinniss MS, GCS was elected President of the Accreditation Council for Genetic Counseling (ACGC), which aims to explore the challenges and opportunities for genetic counselor graduate education. Prior to being elected President, Molly McGinniss MS, CGC was the Program Review Committee chair; she is also currently the Senior Director of Client and Partner Relations at Genome Medical.
July 15, 2021: Tracxn released its 2021 top diagnostic tech startups list, which includes Genome Medical. Tracxn’s list was composed of unicorns, “soonicorns” (companies that have a good chance of becoming unicorns), and “minicorns” (companies that have the potential to become unicorns in the long term), and Genome Medical, among the other tech startups selected, was chosen based on its market size, investment by marquee investors, strength of execution, and future growth potential.
May 20, 2021: In an article for Oliver Wyman Health, Genome Medical’s Co-Founder and CEO Lisa Alderson shares the four ways she believes genomics will advance clinical care, from helping to improve the speed and accuracy of diagnoses of thousands of conditions to deciding the right treatment plan based on pharmacogenomics. Lisa Alderson was also the inaugural winner of the Oliver Wyman Health Innovation Center’s Tom Main Health Innovation Mentorship in 2020.
April 29, 2021: Genome Medical has announced an exclusive licensing of Health Heritage. This time- and cost-saving application will help accelerate care delivery by automating the collection of a patient’s family health history and determining subsequent genetic risk assessments and diagnostics. At first, Genome Medical’s genetic care specialists will use the Health Heritage application to produce educational materials, reports, and recommendations in cases involving cancers and cancer syndromes, but they may also expand its use to other disease categories, like neurological and cardiovascular.
April 14, 2021: In partnership with Genome Medical and Invitae, PTC Therapeutics is launching a PTC Pinpoint Direct™ Program, which allows patients with symptoms or a diagnosis of cerebral palsy (without brain injury) to access genetic tests at no charge. Testing with PTC Pinpoint Direct™ may help show a genetic cause of the symptoms and determine treatment options. Invitae will ofer the genetic testing while Genome Medical will provide expert genetic counseling and administration.
March 31, 2021: To keep up with the demand for telehealth genetic services grow, Genome Medical is expanding its team. Russell Glass, CEO of Ginger, joins the Board as an Independent Director while the company also welcomes Marco Barcella as Chief Product Officer and Brandon Poe as Chief Financial Officer. Marco Barcella previously held strategic product positions at Tiatros and IBM Watson Health, and Brandon Poe was most recently Vice President of Finance at Illumina. Both bring over 20 years of experience in their respective fields.
March 11, 2021: In this episode of “The Next Wave with Young Sohn”, Lisa Alderson shares some of the challenges and benefits that come with genomic-based healthcare. Over the course of 20-minutes, the two talk about how genomics has brought up questions and lead to breakthroughs in insurance, ethics, COVID-19 vaccines, and more.
February 2, 2021: MDisrupt summarizes the top five trends for digital health in 2021, including the expansion of telemedicine, at-home testing, and increased accessibility. Genome Medical was highlighted as a company to watch in the coming year for its work as a specialized telemedicine clinical service,
February 1, 2021: Every year, Rock Health, Fenwick & West, and Goldman Sachs host the “Top 50 in Digital Health Awards” to acknowledge and celebrate the best in digital health, from individuals to companies, advancements to products. This year, Genome Medical took home the “Best Digital Health Company to Work For” award.
January 30, 2021: This five-minute video touches on some of the major healthcare trends for 2021, including telehealth. Genome Medical gets a shoutout from Ruby Gadelrab, CEO of MDisrupt: a health expert platform.
January 26, 2021: Lisa Alderson is featured on the “Slice of Healthcare” podcast. In this 11-minute interview, she talks about her background, how it got her to her current position as Co-Founder and CEO of Genome Medical, and how the company is bringing genomics into everyday care.
December 15, 2020: Lisa Alderson moderates this free webinar on reimaging population health management with genomics. She is joined by panelists Chet Robson DO, MHCDS, FAAFP (Chief Clinical Officer, Walgreens), Tony Slonim MD, DrPH, FACHE (President and CEO, Renown Health), Marcia Guida, MS-CH, MBA, MS-HP, CPC (Senior Director, Aetna CVS Health), and Professor Sir Peter Donnelly, FRS, FMedSci (Founder and CEO, Genomics plc).
November 20, 2020: This feature in the November/December 2020 issue of Clinical OMICs addresses the rise of accessibility and number of virtual platforms for genetic care. Genome Medical’s VP of Clinical Operations, Erynn Gordon explains the rising demand for genetic services, the subsequent role of healthcare providers, and Genome Medical’s approach.
November 19, 2020: Genome Medical’s genetic services are now available to 90 million people across the country through their insurance provider. Now an increased number of patients seeking genetic help and expertise can receive it through Genome Medical’s virtual platform without worrying about in-person visits, accessibility, or affordability.
November 9, 2020: This Oliver Wyman article chronicles the rise of genomics, and predicts six genomic trends for 2030. It also mentions Genome Medical as one of the companies that aims “to expand the genetic specialist network via on-demand, virtual care delivered across the US.:"
October 5, 2020: As part of the Health Podcast Network, Outcomes Rocket is conducting interviews with some of the “most inspiring leaders in healthcare”, including Lisa Alderson.
September 21, 2020: Genome Medical is listed as one of the top companies in Data Bridge Market Research’s competitive landscape for the global genomics medicine market (2020-2027). Along with major players in the space, this report also details the market demand, costs, and industry environment.
August 24, 2020: After featuring Genome Medical in its May/June 2020 issue, Clinical OMICs spotlights Lisa Alderson in its July/August 2020 as one of the “Top Women in Precision Medicine”. In this interview, Lisa speaks about her epiphany for Genome Medical and her ultimate mission: democratizing access to genomic care.
August 20, 2020: Lisa Alderson sat down with Alejandros Cremades' DealMakers podcast to share her journey to Genome Medical. From creating and raising funds for her college campus’ TV to raising $60M for her latest venture, Genome Medical, Lisa shares her tips for raising money, keeping momentum in a startup, and making it as an entrepreneur.
August 14, 2020: LunaPBC and Sheryl Walker MS GCG, one of Genome Medical’s genetic counselors, sit down for an interview about Genome Medical, the services the company offers, and the importance of genetic information.
August 13, 2020: Genome Medical was one of 150 companies featured on CB Insights’ 2020 digital health industry front-runners. Culled from a pool of nearly 8,000 startups, this annual list represents the “most promising” private startups. Genome Medical was recognized in the “virtual care delivery” category.
July 9, 2020: What is telehealth? How does it create a fuss-free access to different services? What are some of its applications? In this virtual panel, Lisa Alderson joins Will Morris of Cleveland Clinic, Ann Mond Johnson of American Telemedicine Association (ATA), Peter Rasmussen of CCAW JV, LLC, and Jennifer Schneider, MD, Livongo Health for a discussion on telehealth, its versatility, and its future. (Lisa is introduced at about 1:05).
July 1, 2020: This write-up of Genome Medical’s latest fundraising round highlights the unique benefits that the company can bring, especially during a pandemic. The company’s platform allows it to reach patients who usually wouldn’t receive care, lower the costs of clinical session, and help medical providers identify the most critical patients - even during a pandemic-induced backlog.
July 1, 2020: Genome Medical announced a $14M round to help develop its platform, which addresses the rapid growth in virtual care needs and the shortage of genomic health care expert. Avestria Ventures participated in this round alongside Canaan Partners, Illumina Ventures, Kaiser Permanente Ventures, Casdin Capital, HealthInvest Equity Partners, and more.
June 30, 2020: In its May/June 2020 issue, Clinical OMICs listed Genome Medical as one of the six precision medicine companies leading the way in 2020. The other recipients were LifeOmic, Karius, MediSapiens, OneOme, and BilliontoOne.
June 10, 2020: Four years ago, Lisa Alderson, Randy Scott, PhD, and Robert Green, MD, MPH, founded Genome Medical Group. In this post, CEO Lisa Alderson shares her hopes for the future as well as her reflections on the 70 million lives that Genome Medical has touched since its inception.
March 31, 2020: Dr. Robert Green, MD, MPH, one of Genome Medical’s co-founders, sits down with Greg Matthews in this podcast interview. Together, the two debunk various myths around genetic testing and answer the question: should everyone have their full genome sequenced?
March 25, 2020: Dr. Robert Green, MD, MPH, one of Genome Medical’s co-founders, talks about the current and future state of genomic-driven medicine in this interview with Clinical OMICS.
March 10, 2020: Genome Medical is offering a direct to consumer (DTC) approach to genetic medicine. In this interview for Mendel’s Pod, Lisa Alderson reviews what the average American consumer does and should know about genetic testing.
February 12, 2020: At the UN Headquarters in New York City, Lisa Alderson addresses the United Nations General Assembly at the 5th International Day of Women and Girls in Science Assembly. (Lisa is introduced at 1:22:23.)
January 30, 2020: Lisa Alderson is the first recipient of the Tom Main Health Innovation Mentorship. The award is named in honor of Tom Main, who founded the Oliver Wyman Health Innovation Center and who passed away unexpectedly in 2018 and honors those who are dedicating themselves to transforming health. As part of the mentorship, Lisa Alderson will be paired with a dedicated mentor to help her and the rest of the Genome Medical team identify and overcome their biggest challenges to driving growth and impact.